Chad Lewis

Senior Director of Chemistry and Manufacturing at K36 Therapeutics

Chad Lewis has worked in a variety of roles since 2010. Chad began as an Assistant Professor at Cornell University in 2010, followed by a role as a Senior Principal Scientist and Principal Scientist at Pfizer from 2015-2020. In 2020, they became an Associate Director of Chemistry at FogPharma, and in 2021 they became the Director of Chemistry and Manufacturing at K36 Therapeutics, Inc.

Chad Lewis has a long and impressive educational history. Chad began their academic career by earning a Bachelor of Science in Chemistry with Honors from the University of Alberta between 1997 and 2002. Chad then attended Boston College from 2003 to 2006, studying Chemistry without obtaining a degree. After that, they earned a Doctor of Philosophy (Ph.D.) in Chemistry from Yale University between 2005 and 2008. Chad then became a Postdoctoral Scholar at The Scripps Research Institute from 2008 to 2010, studying Total synthesis of marine natural products. Most recently, they are pursuing a Masters in Business Administration in Financial Management at Marist College School of Management, which they began in 2020 and is expected to complete in 2023.


Previous companies

Cornell University logo
Pfizer logo


  • Senior Director of Chemistry and Manufacturing

    February 1, 2023 - present

  • Director of Chemistry and Manufacturing

    April, 2021

View in org chart